FIELD: chemistry.
SUBSTANCE: invention relates to chemistry, pharmaceutics and medicine, specifically to a novel chemical compound of L-lysine 9-oxoacridinyl-10-acetate, which stimulates production of interleukin-24 (IL-24) and tumor necrosis factor beta (TNF-β), and has antitumour activity.
EFFECT: technical result: obtaining and describing a new chemical compound stimulating the production of interleukin-24 cytokines and tumor necrosis factor beta and exhibiting anti-tumor activity with low toxicity, L-lysine 9-oxoacridinyl-10-acetate of formula above.
3 cl, 14 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INDOL-3-CARBOXIC ACID DERIVATIVES WITH ANTI-TUMOR ACTIVITY | 2022 |
|
RU2782931C2 |
| APPLICATION OF 9-OCOACRIDINE-10-ACETIC ACID AND/OR ITS SALT COMBINED WITH ANTIESTROGEN AND/OR PROGESTIN FOR TREATMENT OF STROGEN-DEPENDENT TUMOURS, METHOD OF TREATMENT AND SETS | 2007 |
|
RU2346691C2 |
| ANTI-INFLAMMATORY MEDICATION WITH ANTICOAGULANT, ANTITUMOUR AND ANTIMETASTETIC ACTIVITY | 2009 |
|
RU2412712C1 |
| PHARMACOLOGICAL COMBINATION OF POLYCATIONIC CARRIER PEG-PEI-TAT WITH INCLUDED IN IT PLASMID CARRYING THERAPEUTIC GENES HSVtk AND GM-CSF FOR GENE THERAPY OF TUMOROUS DISEASES | 2013 |
|
RU2575077C2 |
| COMPLEX ANTI-TUMORAL PRODUCT | 2020 |
|
RU2751776C2 |
| AGENT FOR TARGETED THERAPY OF MALIGNANT GROWTHS | 2018 |
|
RU2699558C2 |
| BIOTHERAPY METHOD OF LABORATORY RATS WITH GRAFTED GLIOBLASTOMA | 2019 |
|
RU2722268C1 |
| MAGNETIC METAL OXIDE COATED POLYMER NANOPARTICLES AND USE THEREOF | 2008 |
|
RU2472530C2 |
| METHOD OF ORTHOTOPIC HUMAN CEREBRAL GLIOBLASTOMA TRANSPLANTATION INTO CEREBRAL CORTEX PARIETALIS REGION OF IMMUNODEFICIENT MICE | 2020 |
|
RU2742449C1 |
| OCTA-4,5-CARBOXYLIC ACID PHTHALOCYANINE COBALT ESTERS, THEIR INCLUSION COMPLEXES WITH BETA-CYCLODEXTRIN PROPYLENE GLYCOL ESTER AND METHOD OF SUPPRESSION OF TUMOR GROWTH | 2000 |
|
RU2172319C1 |
